History and Challenges of Early Detection of Prostate Cancer
Dr. E. David Crawford reviews the evolution of PSA screening, lessons from major clinical trials, and the development of a practical, risk-adapted approach that combines PSA, biomarkers, MRI, and clinical risk assessment to improve early detection of prostate cancer while reducing unnecessary biopsies and overtreatment.
Read More